H. Langermann

561 total citations
15 papers, 286 citations indexed

About

H. Langermann is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Hematology. According to data from OpenAlex, H. Langermann has authored 15 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 6 papers in Genetics and 5 papers in Hematology. Recurrent topics in H. Langermann's work include Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (5 papers) and Glioma Diagnosis and Treatment (4 papers). H. Langermann is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (5 papers) and Glioma Diagnosis and Treatment (4 papers). H. Langermann collaborates with scholars based in Germany, Austria and United States. H. Langermann's co-authors include G. Henze, H. Riehm, G. Schellong, J. Ritter, Helmut Gadner, H. Riehm, G. Henze, H. Breu, F. Lampert and Hansjörg Riehm and has published in prestigious journals such as European Journal of Pediatrics, Neuropediatrics and Recent results in cancer research.

In The Last Decade

H. Langermann

15 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Langermann Germany 8 218 126 121 58 47 15 286
C Bender-Götze Germany 8 146 0.7× 83 0.7× 200 1.7× 23 0.4× 39 0.8× 16 268
J Cubells Spain 11 100 0.5× 70 0.6× 159 1.3× 28 0.5× 41 0.9× 22 279
Katrin Palk Estonia 6 325 1.5× 233 1.8× 159 1.3× 23 0.4× 79 1.7× 13 384
Pierre Philippet Belgium 8 86 0.4× 106 0.8× 206 1.7× 187 3.2× 21 0.4× 12 332
Mette Levinsen Denmark 10 138 0.6× 104 0.8× 70 0.6× 47 0.8× 32 0.7× 17 218
M Rovira Spain 8 48 0.2× 33 0.3× 155 1.3× 69 1.2× 67 1.4× 12 302
Ramya Ramanujachar United Kingdom 5 251 1.2× 228 1.8× 97 0.8× 20 0.3× 48 1.0× 9 319
Ryota Hosoya Japan 9 56 0.3× 35 0.3× 57 0.5× 18 0.3× 14 0.3× 19 166
S Simon United States 3 123 0.6× 20 0.2× 269 2.2× 42 0.7× 71 1.5× 4 438
Mohammad Sayedur Rahman Saudi Arabia 10 49 0.2× 85 0.7× 72 0.6× 62 1.1× 39 0.8× 13 297

Countries citing papers authored by H. Langermann

Since Specialization
Citations

This map shows the geographic impact of H. Langermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Langermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Langermann more than expected).

Fields of papers citing papers by H. Langermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Langermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Langermann. The network helps show where H. Langermann may publish in the future.

Co-authorship network of co-authors of H. Langermann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Langermann. A scholar is included among the top collaborators of H. Langermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Langermann. H. Langermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Müller-Weihrich, St., G. Henze, H. Langermann, E. Odenwald, & H. Riehm. (1984). Kindliche B-Zell-Lymphome und -Leukämien. Oncology Research and Treatment. 7(4). 205–208. 5 indexed citations
2.
Stephani, Ulrich, et al.. (1984). Slight impairment of psychomotor skills in children after treatment of acute lymphoblastic leukemia. European Journal of Pediatrics. 142(3). 189–197. 26 indexed citations
3.
Lampert, F., G. Henze, H. Langermann, et al.. (1984). Acute Lymphoblastic Leukemia: Current Status of Therapy in Children. Recent results in cancer research. 93. 159–181. 32 indexed citations
4.
Herrmann, F., et al.. (1984). p69,71 Antigen Complex Detected by Monoclonal Antibody Leu 1 in the Identification of Particular Stages of Malignant B‐Cell Differentiation. Scandinavian Journal of Haematology. 32(2). 215–222. 4 indexed citations
5.
Creutzig, U., J. Ritter, H. Langermann, et al.. (1983). Akute myeloische Leukämie bei Kindern: Ergebnisse der kooperativen Therapiestudie BFM-78 nach 3 3/4 Jahren*. Klinische Pädiatrie. 195(3). 152–160. 11 indexed citations
6.
7.
Henze, G., et al.. (1983). Ergebnisse der präventiven Behandlung des Zentralnervensystems bei 275 Kindern mit akuter lymphoblastischer Leukämie*. Klinische Pädiatrie. 195(3). 168–175. 5 indexed citations
8.
Müller-Weihrich, St., G. Henze, A. Jobke, et al.. (1982). BFM-Studie 1975/81 zur Behandlung der Non-Hodgkin-Lymphome hoher Malignität bei Kindern und Jugendlichen*. Klinische Pädiatrie. 194(4). 219–225. 16 indexed citations
9.
Langermann, H., et al.. (1982). Abschätzung der Tumorzellmasse bei der akuten lymphoblastischen Leukämie im Kindesalter: prognostische Bedeutung und praktische Anwendung*. Klinische Pädiatrie. 194(4). 209–213. 48 indexed citations
10.
11.
Neidhardt, M, et al.. (1982). Medulloblastomstudie der Gesellschaft für Pädiatrische Onkologie, ein Zwischenbericht*. Klinische Pädiatrie. 194(4). 257–261. 3 indexed citations
12.
Wehinger, H., P. Gutjahr, Heike Jacobi, et al.. (1982). Randomisierte Studie zur Methotrexatapplikation in der Erhaltungstherapie der akuten lymphoblastischen Leukämie im Kindesalter*. Klinische Pädiatrie. 194(4). 214–218. 1 indexed citations
13.
Fengler, R., G. Henze, H. Langermann, et al.. (1982). Häufigkeit und Behandlungsergebnisse testikulärer Rezidive bei der akuten lymphoblastischen Leukämie im Kindesalter. Klinische Pädiatrie. 194(4). 204–208. 8 indexed citations
14.
Henze, G., H. Langermann, J. Ritter, G. Schellong, & H. Riehm. (1981). Treatment Strategy for Different Risk Groups in Childhood Acute Lymphoblastic Leukemia: A Report From the BFM Study Group. Hämatologie und Bluttransfusion. 26. 87–93. 53 indexed citations
15.
Henze, G., H. Langermann, H. Breu, et al.. (1981). Ergebnisse der Studie BFM 76/79 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen*. Klinische Pädiatrie. 193(3). 145–154. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Bender-Götze Breakdown of academic impact, for papers by J Cubells Breakdown of academic impact, for papers by Katrin Palk Breakdown of academic impact, for papers by Pierre Philippet Breakdown of academic impact, for papers by Mette Levinsen Breakdown of academic impact, for papers by M Rovira Breakdown of academic impact, for papers by Ramya Ramanujachar Breakdown of academic impact, for papers by Ryota Hosoya Breakdown of academic impact, for papers by S Simon Breakdown of academic impact, for papers by Mohammad Sayedur Rahman
Rankless by CCL
2026